PubRank

Bertrand Wechsler

Author PubWeight™ 63.75‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 CNS involvement and treatment with interferon-α are independent prognostic factors in Erdheim-Chester disease: a multicenter survival analysis of 53 patients. Blood 2011 2.59
2 Cardiovascular involvement, an overlooked feature of Erdheim-Chester disease: report of 6 new cases and a literature review. Medicine (Baltimore) 2004 2.27
3 Long-term efficacy and safety of low-dose interferon alpha2a therapy in severe uveitis associated with Behçet disease. Am J Ophthalmol 2008 2.24
4 Low blood concentration of hydroxychloroquine is a marker for and predictor of disease exacerbations in patients with systemic lupus erythematosus. Arthritis Rheum 2006 2.22
5 Vasculitides associated with malignancies: analysis of sixty patients. Arthritis Rheum 2007 1.97
6 Behçet's disease and pregnancy. Arthritis Rheum 2013 1.96
7 Critical role of IL-21 in modulating TH17 and regulatory T cells in Behçet disease. J Allergy Clin Immunol 2011 1.94
8 Association of the R92Q TNFRSF1A mutation and extracranial deep vein thrombosis in patients with Behçet's disease. Arthritis Rheum 2005 1.85
9 Population-based prevalence study of Behçet's disease: differences by ethnic origin and low variation by age at immigration. Arthritis Rheum 2008 1.75
10 Bone involvement in Erdheim-Chester disease: imaging findings including periostitis and partial epiphyseal involvement. Radiology 2005 1.69
11 Cardiac sarcoidosis: a retrospective study of 41 cases. Medicine (Baltimore) 2004 1.68
12 New insights into the pathogenesis of Behçet's disease. Autoimmun Rev 2011 1.60
13 Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: a study of one hundred thirty-three cases compared with a control group. Arthritis Rheum 2003 1.59
14 Variability in the efficacy of interferon-alpha in Erdheim-Chester disease by patient and site of involvement: results in eight patients. Arthritis Rheum 2006 1.58
15 Spectrum of cardiac lesions in Behçet disease: a series of 52 patients and review of the literature. Medicine (Baltimore) 2012 1.33
16 Primary adrenal insufficiency due to bilateral adrenal hemorrhage-adrenal infarction in the antiphospholipid syndrome: long-term outcome of 16 patients. J Clin Endocrinol Metab 2013 1.27
17 Imaging of thoracoabdominal involvement in Erdheim-Chester disease. AJR Am J Roentgenol 2004 1.23
18 Arterial aneurysms in Wegener's granulomatosis: case report and literature review. Semin Arthritis Rheum 2007 1.22
19 Pulmonary arterial hypertension is a major mortality factor in diffuse systemic sclerosis, independent of interstitial lung disease. Arthritis Rheum 2006 1.21
20 Efficacy of interferon alpha in the treatment of refractory and sight threatening uveitis: a retrospective monocentric study of 45 patients. Br J Ophthalmol 2006 1.18
21 Aseptic abscesses: a study of 30 patients with or without inflammatory bowel disease and review of the literature. Medicine (Baltimore) 2007 1.17
22 Behçet's disease. Orphanet J Rare Dis 2012 1.15
23 Late-onset systemic lupus erythematosus: a personal series of 47 patients and pooled analysis of 714 cases in the literature. Medicine (Baltimore) 2004 1.14
24 Treatment of Erdheim-Chester disease with long-term high-dose interferon-α. Semin Arthritis Rheum 2012 1.13
25 Eosinophilic fasciitis (Shulman disease): new insights into the therapeutic management from a series of 34 patients. Rheumatology (Oxford) 2011 1.10
26 Cardiomyopathy related to antimalarial therapy with illustrative case report. Cardiology 2006 1.08
27 Imatinib mesylate for platelet-derived growth factor receptor-beta-positive Erdheim-Chester histiocytosis. Blood 2008 1.07
28 Risk of ovarian failure and fertility after intravenous cyclophosphamide. A study in 84 patients. J Rheumatol 2002 1.06
29 Bilateral adrenal infiltration in Erdheim-Chester disease. Report of seven cases and literature review. J Clin Endocrinol Metab 2007 1.02
30 Outcome of pregnancies in patients with anti-SSA/Ro antibodies: a study of 165 pregnancies, with special focus on electrocardiographic variations in the children and comparison with a control group. Arthritis Rheum 2004 1.01
31 Conjunctival ulcers in Behçet's disease. Ophthalmology 2003 1.01
32 Retropharyngeal and splenic aseptic abscesses treated with prednisone and cyclophosphamide in a patient with ulcerative colitis. Dig Dis Sci 2003 0.92
33 Small vessel involvement in Takayasu's arteritis. Autoimmun Rev 2012 0.90
34 Hydroxychloroquine-induced pigmentation in patients with systemic lupus erythematosus: a case-control study. JAMA Dermatol 2013 0.90
35 Pediatric-onset relapsing polychondritis: case series and systematic review. J Pediatr 2009 0.90
36 Hepatitis C virus infection in systemic lupus erythematosus: a case-control study. J Rheumatol 2003 0.88
37 Tumor antigen markers for the detection of solid cancers in inflammatory myopathies. Cancer Epidemiol Biomarkers Prev 2005 0.88
38 Importance of planning ovulation induction therapy in systemic lupus erythematosus and antiphospholipid syndrome: a single center retrospective study of 21 cases and 114 cycles. Semin Arthritis Rheum 2002 0.86
39 Anetoderma and its prothrombotic abnormalities. J Am Acad Dermatol 2003 0.85
40 Long-term outcome of 32 patients with chorea and systemic lupus erythematosus or antiphospholipid antibodies. Mov Disord 2011 0.84
41 Approaches to immunosuppression in Behçet's disease. Immunotherapy 2013 0.84
42 Evidence of transplacental passage of hydroxychloroquine in humans. Arthritis Rheum 2002 0.83
43 High-dose chemotherapy followed by autologous hematopoietic stem cell transplantation for adult histiocytic disorders with central nervous system involvement. Haematologica 2006 0.83
44 Long-term outcome of arterial lesions in Behçet disease: a series of 101 patients. Medicine (Baltimore) 2012 0.83
45 Ethnicity and association with disease manifestations and mortality in Behçet's disease. Orphanet J Rare Dis 2014 0.82
46 [Erdheim-Chester disease]. Presse Med 2007 0.81
47 Long-term outcome of neuro-Behçet's disease. Arthritis Rheumatol 2014 0.80
48 Tocilizumab in severe and refractory non-infectious uveitis. Clin Exp Rheumatol 2014 0.80
49 Visual loss during interferon-alpha therapy in hepatitis C virus infection. J Hepatol 2002 0.80
50 Efficacy of interferon-alpha for the treatment of Kaposi's sarcoma herpesvirus-associated uveitis. Am J Ophthalmol 2005 0.79
51 Hemochromatosis and femoral head aseptic osteonecrosis: a nonfortuitous association? J Rheumatol 2005 0.79
52 Delayed relapse of Churg-Strauss syndrome manifesting as colon ulcers with mucosal granulomas: 3 cases. J Rheumatol 2002 0.77
53 Pregnane progestin contraception in systemic lupus erythematosus: a longitudinal study of 187 patients. Contraception 2010 0.77
54 Central nervous system angiitis: a series of 31 patients. Clin Rheumatol 2013 0.76
55 Pseudotumoural presentation of neuro-Behcet's disease: case series and review of literature. Rheumatology (Oxford) 2012 0.76
56 Inhibition of tumor necrosis factor alpha and ankylosing spondylitis. N Engl J Med 2003 0.75
57 [Ovulation induction therapy and systemic lupus erythematosus]. Ann Med Interne (Paris) 2003 0.75
58 [Other systemic diseases in the elderly]. Ann Med Interne (Paris) 2002 0.75
59 Left ventricular aneurysm in Behçet's disease. Arch Cardiovasc Dis 2008 0.75
60 18F-fluorodeoxyglucose-positron emission tomography scanning is a useful tool for therapy evaluation of arterial aneurysm in Behçet's disease. Joint Bone Spine 2013 0.75
61 Impaired carbon monoxide diffusing capacity as a marker of limited systemic sclerosis. Eur J Intern Med 2011 0.75